LETTER
Synthesis of 2-Substituted Pyrimidines
1659
Acknowledgment
Table 2 Coupling of Pyrimidin-2-yl Sulfonates 3 with NuH
Ar
O
Ar
O
We are thankful for the financial support from the National Nature
Science Foundation of China (No. 20902073), the Natural Science
Foundation of Gansu Province (No. 096RJZA116), and Scientific
and Technological Innovation Engineering program of Northwest
Normal University (nwnu-kjcxgc-03-64).
R2
N
R2
N
K2CO3 or NaOt-Bu
+ NuH
PEG-400
r.t.
R1
N
OTs
R1
N
Nu
4–6
3
Entry Sulfonate 315 NuH
Product16,17 Yield (%)a
References and Notes
1
2
3a
3b
3c
3d
3e
3f
morpholine
morpholine
morpholine
morpholine
morpholine
morpholine
morpholine
piperidine
piperidine
piperidine
piperidine
piperidine
piperidine
piperidine
EtNH2
4a
4b
4c
4d
4e
4f
84b
81
83
81
85
86
80
82
80
80
83
80
82
84
82
80
n.r.d
80
78
81
n.r.d
82e
86
80
(1) (a) Heldebrant, D.; Jessop, P. G. J. Am. Chem. Soc. 2003,
125, 5600. (b) Hesis, L.; Gais, H. J. Tetrahedron Lett. 1995,
36, 3833. (c) Haimov, A.; Neumann, R. Chem. Commun.
2002, 876. (d) Wang, X.-C.; Quan, Z.-J.; Zhang, Z.
Tetrahedron 2007, 63, 8227.
3
(2) (a) Chandrasekhar, S.; Narsihmulu, Ch.; Sultana, S. S.;
Reddy, N. R. Org. Lett. 2002, 4, 4399. (b) Ackermann, L.;
Vicente, R. Org. Lett. 2009, 11, 4922. (c) Zhou, W.-J.;
Wang, K.-H.; Wang, J.-X. J. Org. Chem. 2009, 74, 5599.
(3) (a) Biginelli, P. Gazz. Chim. Ital. 1893, 23, 360. (b) Kappe,
C. O. Tetrahedron 1993, 49, 6937. (c) Kappe, C. O. Acc.
Chem. Res. 2000, 33, 879. (d) Kappe, C. O.; Stadler, A.
Org. React. 2004, 63, 1. (e) Dallinger, D.; Stadler, A.;
Kappe, C. O. Pure Appl. Chem. 2004, 76, 1017. (f) Gong,
L. Z.; Chen, X. H.; Xu, X. Y. Chem. Eur. J. 2007, 13, 8920.
(g) Kolosov, M. A.; Orlov, V. D. Mol. Diversity 2009, 13, 5.
(h) Quan, Z.-J.; Zhang, Z.; Da Y, X.; Wang, X.-C. Chin. J.
Org. Chem. 2009, 29, 876; in Chinese.
4
5
6
7
3g
3a
3b
3c
3d
3e
3f
4g
4h
4i
8
9
10
11
12
13
14
15c
16c
17
18
19
20
21
22
23
24
4j
4k
4l
(4) (a) Kappe, C. O. Eur. J. Med. Chem. 2000, 35, 1043.
(b) Deres, K.; Schroder, C. H.; Paessens, A.; Goldmann, S.;
Hacker, H. J.; Weber, O.; Kraemer, T.; Niewoehner, U.;
Pleiss, U.; Stoltefuss, J.; Graef, E.; Koletzki, D.;
4m
4n
4o
4p
Masantschek, R. N. A.; Reimann, A.; Jaeger, R.; Groß, R.;
Beckermann, B.; Schlemmer, K.-H.; Haebich, D.;
Rubsamen-Waigmann, H. Science 2003, 299, 893.
(c) Lengar, A.; Kappe, C. O. Org. Lett. 2004, 6, 771.
(d) Sing, K.; Arora, D.; Poremsky, E.; Lowery, J.; Moreland,
R. S. Eur. J. Med. Chem. 2009, 44, 1997. (e) Singh, K.;
Arora, D.; Singh, K.; Singh, S. Mini Rev. Med. Chem. 2009,
9, 95.
3g
3a
3a
3a
3a
3b
3d
3a
3a
3a
3a
HOCH2CH2NH2
4-MeC6H4NH2
4-MeC6H4SH
4-MeC6H4SH
4-MeC6H4SH
HOOCCH2SH
EtOH
5a
5b
5c
(5) (a) Snider, B. B.; Shi, Z. J. Org. Chem. 1993, 58, 3828.
(b) Patil, A. D.; Kumar, N. V.; Kokke, W. C.; Bean, M. F.;
Freyer, A. J.; DeBrosse, C.; Mai, S.; Truneh, A.; Gaulkner,
D. J.; Carte, B.; Breen, A. L.; Hertzberg, R. P.; Johnson, R.
K.; Westly, J. W.; Potts, B. C. J. Org. Chem. 1995, 60, 1182.
(c) Aron, Z. D.; Overman, L. E. Chem. Commun. 2004, 253.
(6) The Merck Index, An Encyclopedia of Chemicals, Drugs and
Biologicals, 13th ed.; Merck: Whitehouse Station, 2001.
(7) (a) Kappe, C. O.; Roschger, P. J. Heterocycl. Chem. 1989,
26, 55. (b) Gholap, A. R.; Toti, K. S.; Shirazi, F.;
Deshpande, M. V.; Srinivasan, K. V. Tetrahedron 2008, 64,
10214.
(8) (a) Watanabe, M.; Koike, H.; Ishiba, T.; Okada, T.; Seo, S.;
Hirai, K. Bioorg. Med. Chem. 1997, 5, 437. (b) Kim, D. C.;
Lee, Y. R.; Yang, B.-S.; Shin, K. J.; Kim, D. J.; Chung,
B. Y.; Yoo, K. H. Eur. J. Med. Chem. 2003, 38, 525.
(c) Kasparec, J.; Adams, J. L.; Sisko, J.; Silva, D. J.
Tetrahedron Lett. 2003, 44, 4567. (d) Gayo, L. M.; Suto,
M. J. Tetrahedron Lett. 1997, 38, 211. (e) Matloobi, M.;
Kappe, C. O. J. Comb. Chem. 2007, 9, 275. (f) Obrecht, D.;
Abrecht, C.; Grieder, A.; Villalgordo, J. M. Helv. Chim. Acta
1997, 80, 65. (g) Vanden Eynde, J. J.; Labuche, N.;
Van Haverbeke, Y.; Tietze, L. ARKIVOC 2003, (xv), 22.
(9) Vanden Eynde, J. J.; Audiart, N.; Canonne, V.; Michel, S.;
Van Haverbeke, Y.; Kappe, C. O. Heterocycles 1997, 45,
1967.
6a
6b
6c
i-PrOH
BnOH
a Isolated yield.
b Reaction conditions for compounds 4 and 5: 3 (1.0 mmol), amine
(1.5 mmol), K2CO3 (1.5 mmol), PEG-400 (2.0 g), r.t., 30 min.
c Completed within 60 min.
d No reaction.
e Reaction conditions for compounds 6a–c: 3 (1.0 mmol), NuH (1.5
mmol), NaOt-Bu (1.5 mmol), PEG-400 (2.0 g), r.t., 90 min.
PEG-400 as a readily commercially available green sol-
vent with low cost and recyclable property.
Supporting Information for this article is available online at
Synlett 2010, No. 11, 1657–1660 © Thieme Stuttgart · New York